Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li><strong>As per information available on <keyword id="35140" type="General" weightage="50" keywordseo="bse" source="Orion">BSE</keyword>, <keyword id="44642" type="General" weightage="80" keywordseo="sun-pharma" source="Orion">Sun Pharma</keyword> had clocked revenue of Rs 15,585.98 crore in 2021-22.</strong></li><li><strong>The development follows an inspection of the facility by the <keyword id="6356255" type="General" weightage="50" keywordseo="us-food-and-drug-administration" source="Orion">US Food and Drug Administration</keyword> (<keyword id="44669" type="General" weightage="80" keywordseo="usfda" source="Orion">USFDA</keyword>) from April 26 to May 9, 2022.</strong></li><li><strong><keyword id="1618324" type="General" weightage="100" keywordseo="import-alert" source="Orion">Import alert</keyword> implies that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until the facility becomes compliant with cGMP.</strong></li></ul><br />Sun Pharmaceutical Industries Ltd on Thursday said its Halol facility in <keyword id="6354766" type="General" weightage="20" keywordseo="gujarat" source="Orion">Gujarat</keyword> has been listed under import alert by the USFDA with products manufactured at the unit now are subject to refusal of admission in the US market. The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022. <br /><br /> "We now wish to inform you that the company has received a communication from the USFDA stating that the facility has been listed under Import Alert," Sun Pharma said in a regulatory filing. <br /><br /> Import alert implies that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until the facility becomes compliant with cGMP (current good manufacturing practice) standards, it added. <br /><br /> The company further said, "The USFDA has excluded 14 products from this import alert subject to certain conditions." <br /><br /> For the year ended 31-March-2022, supplies to the US market from the Halol facility accounted for approximately 3 per cent of the company's consolidated revenues, including the 14 excluded products, it added. <br /><br /> As per information available on BSE, Sun Pharma had clocked revenue of Rs 15,585.98 crore in 2021-22. <br /><br /> Sun Pharma said it "continues to cooperate with the USFDA and will undertake all necessary steps to resolve these issues and to ensure that the regulator is completely satisfied with the company's remedial action". <br /><br />SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/fpis-invest-over-36000-crore-in-indian-equities-in-november-financial-services-is-top-favourite/articleshow/96082197.cms">FPIs invest over ₹36,000 crore in Indian equities in November – Financial services is top favourite</a><br /><a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/news/wordle-is-the-most-googled-topic-in-2022-heres-how-it-started-and-how-to-play-it/slidelist/96081579.cms">Wordle is the most googled topic in 2022, here's how it started and how to play it</a><br /><a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/news/dysons-futuristic-air-purifying-noise-canceling-headphones-are-ready-to-hit-the-market-from-january-2023/articleshow/96081759.cms">Dyson’s futuristic air-purifying, noise-canceling headphones are ready to hit the market from January 2023</a>

Sun Pharma's Halol unit put under 'import alert' by USFDA

New Delhi, Jan 10 () Leading stock exchange BSE on Friday said 10 companies, including Larsen &amp; Toubro Ltd, Sun Pharmaceutical Industries Ltd and BHEL, have filed applications with the bourse to list their commercial papers (CPs) for a total issue size of Rs 5,745 crore.
<p> Larsen &amp; Toubro Ltd, Manappuram Finance Ltd, ECL Finance Ltd, Sun Pharmaceutical Industries Ltd and BHEL have made applications to list CPs for issue size of Rs 2,995 crore, Rs 775 crore, Rs 500 crore, Rs 500 crore and Rs 450 crore, respectively, the BSE said in a release.
</p><p> Besides, Redington (India) Ltd, Kotak Mahindra Prime Ltd, Muthoot Homefin (India) Ltd, The Ramco Cements Ltd and IIFL Wealth Finance Ltd have filed applications to list their CPs for issue size of Rs 175 crore, Rs 140 crore, Rs 100 crore, Rs 75 crore, and Rs 35 crore, respectively.
</p><p> After the process, the effective date of listing CPs with the exchange will be January 13, it added.
</p><p> "Till date 77 issuers have done 582 issuances of commercial papers and have successfully listed CPs of Rs 1,72,984 crore on BSE. The weighted average yield of these issuances is 6.13 per cent with an average tenor of 149 days," BSE noted.
</p><p> A CP is an unsecured money market instrument issued in the form of promissory notes that enables highly rated corporate borrowers to diversify their sources of short-term borrowing and provides an additional instrument to investors.
</p><p> Such instruments can be issued for maturities between a minimum of 7 days and a maximum of one year from the date of issue. 
</p> CPs are usually issued at a discount from face value and reflect prevailing market interest rates.   AST
RVK

10 firms to list commercial papers on BSE for Rs 5,745 crore issue size

<p><div class="KonaFilter image-container display-table float_right"><div><div class="image on-image"><p class="source"><span>REUTERS/Nancy Wiechec</span></p><p class="caption">Loretta Lynch in Phoenix.</p></div><p></p></div></div>Federal prosecutors may bring charges of price collusion against a group of generic drugmakers before the end of the year, Bloomberg reports.</p><p>The Department of Justice started this investigation two years ago, and it includes over a dozen drug companies - like Mylan, Lannett, and Teva to name a few - and dozens of drugs. Charges could come down as early as December, Bloomberg's <span>David McLaughlin and Caroline Chen are reporting.</span></p><p>A bunch of the stocks involved with the investigation are falling on this news. Here's a quick sampling:</p><ul><li>Mylan is down 5%.</li><li>Lannet is down 18%.</li><li>Teva is down over 6%.</li><li>Actavis is down about 3%</li><li><span>Impax Laboratories is down 12%</span></li></ul><p><span><span>Covis Pharma </span><span>Holdings Sarl, Sun Pharmaceutical Industries Ltd., Mayne Pharma </span><span>Group Ltd., Endo International Plc's subsidiary Par </span><span>Pharmaceutical Holdings and Taro Pharmaceutical Industries Ltd. also received subpoenas in connection to this investigation.</span></span></p><p><span><span>Generic drugs are supposed to keep healthcare costs down. But the government may be about to allege that these companies worked together to keep prices higher instead of allowing market competition to set pricing.</span></span></p><p><span><span>Charges of price collusion within the industry are not unheard of. In fact, Lannett, Mylan, Impax and Par are all involved in a separate alleged price collusion class action suit over<span> the price of digoxin, a heart drug, and doxycycline, an antibiotic. That suit was filed in April, and Allergan and West-Ward Pharmaceuticals are also involved in that suit.</span></span></span>  </p>    <div class="margin-top">        <h3>NOW WATCH: <a href="http://www.businessinsider.com/what-happens-when-interest-rates-go-negative-ken-rogoff-2016-10">Here's what happens when interest rates go negative</a></h3>        <div>            <div>        <div class="ooyala-video-player" data-video-autoplay="false" data-video-id="M2c3ZwNjE6GPPIfI9mJGscYp5wQYmgrZ" data-player-variable="ooyalapopvideo" id="ooyalaplayer_popvideo" style="width:1280px;height:720px"></div>        </div>        </div>            </div>

You Searched For "Sun Pharmaceutical Industries Ltd" and got 3 results

Sun Pharma's Halol unit put under 'import alert' by USFDA

PTI

10 firms to list commercial papers on BSE for Rs 5,745 crore issue size

PTI

The Feds are about to nail a bunch of drug companies for price fixing

Linette Lopez

Popular Keywords

Buying Guides